Antiviral Trial: HIV Drug Failed To Help COVID-19 Patients

Name: Antiviral Trial: HIV Drug Failed To Help COVID-19 Patients
Uploaded: 2020-03-18T23:33:19+00:00
Duration: P32S
Description: Some of the first clinical data for a potential coronavirus treatment showed it did not help. This was in regards to patients with severe cases of COVID-19,

Video Credit: Wochit - Duration: 00:32s - Published on March 18, 2020

Antiviral Trial: HIV Drug Failed To Help COVID-19 Patients

Some of the first clinical data for a potential coronavirus treatment showed it did not help.

This was in regards to patients with severe cases of COVID-19, according to Business Insider.

Scientists in China enrolled 199 coronavirus patients into a study from January 18 through February 3.

They randomly assigned them to get either the HIV drug Kaletra plus standard of care or just regular care.

The drug did not show benefits in keeping patients alive, unfortunately.

0 shares	Share Tweet Save Post Send

Related videos from verified sources

Genentech to Begin Clinical Trial of Drug Treatment for COVID-19 [Video]

Genentech to Begin Clinical Trial of Drug Treatment for COVID-19

KPIX 5 spoke to Dr. Levi Garraway, chief medical officer at Genentech, about a pending clinical trial of Actemra, an anti-inflammatory medicine, as a possible treatment for COVID-19 patients. (3-27-20)

Credit: CBS 5 SF KPIX Duration: 01:54Published on March 28, 2020

UH one of first in nation to begin clinical trials for drug to help patients with COVID-19 [Video]

UH one of first in nation to begin clinical trials for drug to help patients with COVID-19

As the country deals with the coronavirus crisis sweeping the nation, University Hospitals will lead the way in testing an antiviral to combat COVID-19.

Credit: Rumble Duration: 02:35Published on March 21, 2020

Antiviral Trial: HIV Drug Failed To Help COVID-19 Patients

You Might Like

Related videos from verified sources